1
R/stimulator. This was referred to as the "Phase 2 trial." Fifty-eight subjects received Nucleus Freedom-based 10 mm devices under the Phase 2 multicenter study protocol.??The preliminary report of the multicenter clinical trial included 68 of the present cohort 12. The subjects ranged in age from 19.6 years to 82.3 years, with a mean age of 58.9 years (SD =14.8 years; median = 59.8 years). Thirty
What is Kliqqi?

Kliqqi is an open source content management system that lets you easily create your own user-powered website.

Latest Comments